Improvement of Hepatitis B Virus DNA Vaccines by Plasmids Coexpressing Hepatitis B Surface Antigen and Interleukm-2

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 169-178

  Chow, Yen Hung ^a,b   Huang, Wei Lun ^a   Chi, Wei Kuang ^c   Chu, Y I Ding ^c   Tao, M I Hua ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c DEVELOPMENT CENTER FOR BIOTECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2;

ADOLESCENT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; VACCINATION;

ANIMALS; CELL LINE; DNA, VIRAL; FEMALE; GENE EXPRESSION; GENETIC ENGINEERING; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMIDS; PROTEIN PRECURSORS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; VACCINES, DNA;

EID: 0031060327     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.169-178.1997     Document Type: Article

References (58)

1. Acsadi, G., G. Dickson, D. R. Love, A. Jani, F. S. Walsh, A. Gurusinghe, J. A. Wolff, and K. E. Davies. 1991. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352:815-818.
2. Alper, C. A., M. S. Kruskull, D. Marcus Bagley, D. E. Craven, A. J. Katz, S. J. Brink, J. L. Dienstag, Z. Awdeh, and E. J. Yunis. 1989. Genetic prediction of nonresponse to hepatitis B vaccine. N. Engl. J. Med. 321:708-712.
3. Anderson, G., O. Urbano, P. Fedorka-Cray, A. Newell, J. Nunberg, and M. Doyle. 1987. Interleukin-2 and protective immunity in Haemophilus pleuropneumoniae: preliminary studies. Vaccines (Cold Spring Harbor) 1987:22-25.
4. Bretscher, P. 1992. The two-signal model of lymphocyte activation twenty-one years later. Immunol. Today 13:74-76.
5. Chen, T. T., M. H. Tao, and R. Levy. 1994. Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor. J. Immunol. 153:4775-4787.
6. Craven, D. E., Z. L. Awdeh, L. M. Kunches, E. J. Yunis, J. L. Dienstag, B. G. Werner, B. F. Polk, D. R. Syndman, R. Platt, and C. S. Crumpacker. 1986. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann. Intern. Med. 105:356-360.
7. Davidson, M., and S. Krugman. 1986. Recombinant yeast hepatitis B vaccine compared with plasma-derived vaccine: immunogenicity and effect of a booster dose. J. infect. 13:31-38.
8. Dong, P., B. C., and R. J. Y. Ho. 1995. Cytokines as vaccine adjuvants: current status and potential applications, p. 625-643. In M. F. Powell and M. J. Newman (ed.), Vaccine design: the subunit and adjuvant approach. Plenum Press, New York, N.Y.
9. Donnelly, J. J., J. B. Ulmer, and M. A. Liu. 1994. Immunization with DNA. J. Immunol. Methods 176:145-152.
10. Fortuin, M., J. Chotard, A. D. Jack, N. P. Maine, M. Mendy, A. J. Hall, H. M. Inskip, M. O. George, and H. C. Whittle. 1993. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet 3-41:1129-1131.
11. Ganem, D., and H. E. Varmus. 1987. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56:651-693.
12. Good, M. F., D. Pombo, M. N. Lunde, W. L. Maloy, R. Halenbeck, K. Koths, L. H. Miller, and J. A. Berzufsky. 1988. Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2. J. Immunol. 141:972-977.
13. Hazama, M., A. Mayumi Aono, N. Asakawa, S. Kuroda, S. Hinuma, and Y. Fujisawa. 1993. Adjuvant-independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2. Vaccine 11:629-636.
14. Hazama, M., A. Mayumi Aono, T. Miyazaki, S. Hinuma, and Y. Fujisawa. 1993. Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat labile enterotoxin and interleukin-2. Immunology 78:643-649.
15. Heath, A. W. 1995. Cytokines as immunoiogical adjuvants, p. 645-658. In M. F. Powell and M. J. Newman (ed.), Vaccine design: the subunit and adjuvant approach. Plenum Press, New York, N.Y.
16. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon gamma or interleukin 4 during the resolution of progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
17. Hohlfeld, R., and A. G. Engel. 1994. The immunobiology of muscle. Immunol. Today 15:269-274.
18. Irvine, K. R., J. B. Rao, S. A. Rosenberg, and N. P. Restifo. 1996. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 136:238-245.
19. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321-331.
20. Kawamura, H., S. Rosenberg, and J. A. Berzufsky. 1985. Immunization with antigen and interleukin-2 in vivo overcomes Ir gene low responsiveness. J. Exp. Med. 162:381-386.
21. Lagging, L. M., K. Meyer, D. Hoft, M. Houghton, R. B. Belshe, and R. Ray. 1995. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:5859-5863.
22. Lowrie, D. B., R. E. Tascon, M. J. Colston, and C. L. Silva. 1994. Towards a DNA vaccine against tuberculosis. Vaccine 12:1537-1540.
23. Major, M. E., L. Vitvitski, M. A. Mink, M. Schleef, R. G. Whalen, C. Trepo, and G. Inchauspe. 1995. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 69:5798-5805.
24. Manickan, E., R. J. Rouse, Z. Yu, W. S. Wire, and B. T. Rouse. 1995. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J. Immunol. 155:259-265.
25. Martins, L. P., L. L. Lau, M. S. Asano, and R. Ahmed. 1995. DNA vaccination against persistent viral infection. J. Virol. 69:2574-2582.
26. McDonnell, W. M., and F. K. Askari. 1996. DNA vaccines. N. Engl. J. Med. 334:42-45.
27. Meuer, S. C., H. Dumann, K. H. Meyer zum Buschenfelde, and H. Kohler. 1989. Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination. Lancet i:15-17.
28. Michel, M. L., H. L. Davis, M. Schleef, M. Mancini, P. Tiollais, and R. G. Whalen. 1995. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA 92:5307-5311.
29. Milich, D. R., G. G. Leroux Roels, R. E. Louie, and F. V. Chisari. 1984. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions. J. Exp. Med. 159:41-56.
30. Milich, D. R., G. B. Thornton, A. R. Neurath, S. B. Kent, M. L. Michel, P. Tiollais, and F. V. Chisari. 1985. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228:1195-1199.
31. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
32. Mosmann, T. R., and R. L. Coffman. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46:111-147.
33. Nunberg, J. H., M. V. Doyle, S. M. York, and C. J. York. 1989. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proc. Natl. Acad. Sci. USA 86:4240-4243.
34. Osterrieder, N., R. Wagner, C. Brandmuller, P. Schmidt, H. Wolf, and O. R. Kaaden. 1995. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology 208:500-510.
35. Parronchi, P., D. Macchia, M. P. Piccinni, P. Biswas, C. Simonelli, E. Maggi, M. Ricci, A. A. Ansari, and S. Romagnani. 1991. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA 88:4538-4542.
36. Raz, E., A. Watanabe, S. M. Baird, R. A. Eisenberg, T. B. Parr, M. Lotz, T. J. Kipps, and D. A. Carson. 1993. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl. Acad. Sci. USA 90:4523-4527.
37. Rhodes, G. H., A. M. Abai, M. Margalith, R. A. Kuwahara, J. Morrow, S. E. Parker, and V. J. Dwarki. 1994. Characterization of humoral immunity after DNA injection. Dev. Biol. Stand. 82:229-236.
38. Romagnani, S. 1991. Human TH1 and TH2 subsets: doubt no more. Immunol. Today 12:256-257.
39. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M. D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354.
40. Schirmbeck, R., W. Bohm, K. Ando, F. V. Chisari, and J. Reimann. 1995. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 69:5929-5934.
41. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866-9870.
42. Seder, R. A., and W. E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12:635-673.
43. Sher, A., and R. L. Coffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385-409.
44. Tiollais, P., C. Pourcel, and A. Dejean. 1985. The hepatitis B virus. Nature 317:489-495.
45. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
46. Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. I. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156-4160.
47. Watanabe, A., E. Raz, H. Kohsaka, H. Tighe, S. M. Baird, T. J. Kipps, and D. A. Carson. 1993. Induction of antibodies to a kappa V region by gene immunization. J. Immunol. 151:2871-2876.
48. Watson, J. 1979. Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J. Exp. Med. 150:1510-1519.
49. Weinberg, A., and T. C. Merigan. 1988. Recombinant intcrlcukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines. J. Immunol. 140:294-299.
50. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
51. Wolff, J. A., P. Williams, G. Acsadi, S. Jiao, A. Jani, and W. Chong. 1991. Conditions affecting direct gene transfer into rodent muscle in vivo. BioTechniques 11:474-485.
52. Xiang, Z., and H. C. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129-135.
53. Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng, and H. C. Ertl. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199: 132-140.
54. Xiang, Z. Q., S. L. Spitalnik, J. Cheng, J. Erikson, B. Wojczyk, and H. C. Ertl. 1995. Immune responses to nucleic acid vaccines to rabies virus. Virology 209:569-579.
55. Yang, W., G. J. Waine, and D. P. McManus. 1995. Antibodies to Schistosoma japonicum (Asian bloodfluke) paramyosin induced by nucleic acid vaccination. Biochem. Biophys. Res. Commun. 212:1029-1039.
56. Yasutomi, Y., H. L. Robinson, S. Lu, F. Mustafa, C. Lekutis, J. Arthos, J. I. Mullins, G. Voss, K. Manson, M. Wyand, and N. L. Letvin. 1996. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol. 70:678-681.
57. Yokoyama, M., J. Zhang, and J. L. Whitton. 1995. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:2684-2688.
58. Yssel, H., K. E. Johnson, P. V. Schneider, J. Wideman, A. Terr, R. Kastelein, and J. E. De Vries. 1992. T cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+ T cell clones. J. Immunol. 148:738-745.